Peptide Vaccine Market
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined ... Read More
1 Introduction to Research & Analysis Reports 1.1 Inactivated Polio Vaccine Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Inactivated Polio Vaccine Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Inactivated Polio Vaccine Overall Market Size 2.1 Global Inactivated Polio Vaccine Market Size: 2021 VS 2028 2.2 Global Inactivated Polio Vaccine Revenue, Prospects & Forecasts: 2017-2028 2.3 Global Inactivated Polio Vaccine Sales: 2017-2028 3 Company Landscape 3.1 Top Inactivated Polio Vaccine Players in Global Market 3.2 Top Global Inactivated Polio Vaccine Companies Ranked by Revenue 3.3 Global Inactivated Polio Vaccine Revenue by Companies 3.4 Global Inactivated Polio Vaccine Sales by Companies 3.5 Global Inactivated Polio Vaccine Price by Manufacturer (2017-2022) 3.6 Top 3 and Top 5 Inactivated Polio Vaccine Companies in Global Market, by Revenue in 2021 3.7 Global Manufacturers Inactivated Polio Vaccine Product Type 3.8 Tier 1, Tier 2 and Tier 3 Inactivated Polio Vaccine Players in Global Market 3.8.1 List of Global Tier 1 Inactivated Polio Vaccine Companies 3.8.2 List of Global Tier 2 and Tier 3 Inactivated Polio Vaccine Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Inactivated Polio Vaccine Market Size Markets, 2021 & 2028 4.1.2 Government 4.1.3 Private Sector 4.2 By Type - Global Inactivated Polio Vaccine Revenue & Forecasts 4.2.1 By Type - Global Inactivated Polio Vaccine Revenue, 2017-2022 4.2.2 By Type - Global Inactivated Polio Vaccine Revenue, 2023-2028 4.2.3 By Type - Global Inactivated Polio Vaccine Revenue Market Share, 2017-2028 4.3 By Type - Global Inactivated Polio Vaccine Sales & Forecasts 4.3.1 By Type - Global Inactivated Polio Vaccine Sales, 2017-2022 4.3.2 By Type - Global Inactivated Polio Vaccine Sales, 2023-2028 4.3.3 By Type - Global Inactivated Polio Vaccine Sales Market Share, 2017-2028 4.4 By Type - Global Inactivated Polio Vaccine Price (Manufacturers Selling Prices), 2017-2028 5 Sights By Application 5.1 Overview 5.1.1 By Application - Global Inactivated Polio Vaccine Market Size, 2021 & 2028 5.1.2 Pediatrics 5.1.3 Adults 5.2 By Application - Global Inactivated Polio Vaccine Revenue & Forecasts 5.2.1 By Application - Global Inactivated Polio Vaccine Revenue, 2017-2022 5.2.2 By Application - Global Inactivated Polio Vaccine Revenue, 2023-2028 5.2.3 By Application - Global Inactivated Polio Vaccine Revenue Market Share, 2017-2028 5.3 By Application - Global Inactivated Polio Vaccine Sales & Forecasts 5.3.1 By Application - Global Inactivated Polio Vaccine Sales, 2017-2022 5.3.2 By Application - Global Inactivated Polio Vaccine Sales, 2023-2028 5.3.3 By Application - Global Inactivated Polio Vaccine Sales Market Share, 2017-2028 5.4 By Application - Global Inactivated Polio Vaccine Price (Manufacturers Selling Prices), 2017-2028 6 Sights by Region 6.1 By Region - Global Inactivated Polio Vaccine Market Size, 2021 & 2028 6.2 By Region - Global Inactivated Polio Vaccine Revenue & Forecasts 6.2.1 By Region - Global Inactivated Polio Vaccine Revenue, 2017-2022 6.2.2 By Region - Global Inactivated Polio Vaccine Revenue, 2023-2028 6.2.3 By Region - Global Inactivated Polio Vaccine Revenue Market Share, 2017-2028 6.3 By Region - Global Inactivated Polio Vaccine Sales & Forecasts 6.3.1 By Region - Global Inactivated Polio Vaccine Sales, 2017-2022 6.3.2 By Region - Global Inactivated Polio Vaccine Sales, 2023-2028 6.3.3 By Region - Global Inactivated Polio Vaccine Sales Market Share, 2017-2028 6.4 North America 6.4.1 By Country - North America Inactivated Polio Vaccine Revenue, 2017-2028 6.4.2 By Country - North America Inactivated Polio Vaccine Sales, 2017-2028 6.4.3 US Inactivated Polio Vaccine Market Size, 2017-2028 6.4.4 Canada Inactivated Polio Vaccine Market Size, 2017-2028 6.4.5 Mexico Inactivated Polio Vaccine Market Size, 2017-2028 6.5 Europe 6.5.1 By Country - Europe Inactivated Polio Vaccine Revenue, 2017-2028 6.5.2 By Country - Europe Inactivated Polio Vaccine Sales, 2017-2028 6.5.3 Germany Inactivated Polio Vaccine Market Size, 2017-2028 6.5.4 France Inactivated Polio Vaccine Market Size, 2017-2028 6.5.5 U.K. Inactivated Polio Vaccine Market Size, 2017-2028 6.5.6 Italy Inactivated Polio Vaccine Market Size, 2017-2028 6.5.7 Russia Inactivated Polio Vaccine Market Size, 2017-2028 6.5.8 Nordic Countries Inactivated Polio Vaccine Market Size, 2017-2028 6.5.9 Benelux Inactivated Polio Vaccine Market Size, 2017-2028 6.6 Asia 6.6.1 By Region - Asia Inactivated Polio Vaccine Revenue, 2017-2028 6.6.2 By Region - Asia Inactivated Polio Vaccine Sales, 2017-2028 6.6.3 China Inactivated Polio Vaccine Market Size, 2017-2028 6.6.4 Japan Inactivated Polio Vaccine Market Size, 2017-2028 6.6.5 South Korea Inactivated Polio Vaccine Market Size, 2017-2028 6.6.6 Southeast Asia Inactivated Polio Vaccine Market Size, 2017-2028 6.6.7 India Inactivated Polio Vaccine Market Size, 2017-2028 6.7 South America 6.7.1 By Country - South America Inactivated Polio Vaccine Revenue, 2017-2028 6.7.2 By Country - South America Inactivated Polio Vaccine Sales, 2017-2028 6.7.3 Brazil Inactivated Polio Vaccine Market Size, 2017-2028 6.7.4 Argentina Inactivated Polio Vaccine Market Size, 2017-2028 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Inactivated Polio Vaccine Revenue, 2017-2028 6.8.2 By Country - Middle East & Africa Inactivated Polio Vaccine Sales, 2017-2028 6.8.3 Turkey Inactivated Polio Vaccine Market Size, 2017-2028 6.8.4 Israel Inactivated Polio Vaccine Market Size, 2017-2028 6.8.5 Saudi Arabia Inactivated Polio Vaccine Market Size, 2017-2028 6.8.6 UAE Inactivated Polio Vaccine Market Size, 2017-2028 7 Manufacturers & Brands Profiles 7.1 Sanofi 7.1.1 Sanofi Corporate Summary 7.1.2 Sanofi Business Overview 7.1.3 Sanofi Inactivated Polio Vaccine Major Product Offerings 7.1.4 Sanofi Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.1.5 Sanofi Key News 7.2 GSK 7.2.1 GSK Corporate Summary 7.2.2 GSK Business Overview 7.2.3 GSK Inactivated Polio Vaccine Major Product Offerings 7.2.4 GSK Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.2.5 GSK Key News 7.3 Bibcol 7.3.1 Bibcol Corporate Summary 7.3.2 Bibcol Business Overview 7.3.3 Bibcol Inactivated Polio Vaccine Major Product Offerings 7.3.4 Bibcol Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.3.5 Bibcol Key News 7.4 Serum Institute 7.4.1 Serum Institute Corporate Summary 7.4.2 Serum Institute Business Overview 7.4.3 Serum Institute Inactivated Polio Vaccine Major Product Offerings 7.4.4 Serum Institute Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.4.5 Serum Institute Key News 7.5 Tiantan Biological 7.5.1 Tiantan Biological Corporate Summary 7.5.2 Tiantan Biological Business Overview 7.5.3 Tiantan Biological Inactivated Polio Vaccine Major Product Offerings 7.5.4 Tiantan Biological Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.5.5 Tiantan Biological Key News 7.6 Panacea Biotec 7.6.1 Panacea Biotec Corporate Summary 7.6.2 Panacea Biotec Business Overview 7.6.3 Panacea Biotec Inactivated Polio Vaccine Major Product Offerings 7.6.4 Panacea Biotec Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.6.5 Panacea Biotec Key News 7.7 Bio-Med 7.7.1 Bio-Med Corporate Summary 7.7.2 Bio-Med Business Overview 7.7.3 Bio-Med Inactivated Polio Vaccine Major Product Offerings 7.7.4 Bio-Med Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.7.5 Bio-Med Key News 7.8 Halfkin Bio-Pharmaceuticals 7.8.1 Halfkin Bio-Pharmaceuticals Corporate Summary 7.8.2 Halfkin Bio-Pharmaceuticals Business Overview 7.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Major Product Offerings 7.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales and Revenue in Global (2017-2022) 7.8.5 Halfkin Bio-Pharmaceuticals Key News 8 Global Inactivated Polio Vaccine Production Capacity, Analysis 8.1 Global Inactivated Polio Vaccine Production Capacity, 2017-2028 8.2 Inactivated Polio Vaccine Production Capacity of Key Manufacturers in Global Market 8.3 Global Inactivated Polio Vaccine Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Inactivated Polio Vaccine Supply Chain Analysis 10.1 Inactivated Polio Vaccine Industry Value Chain 10.2 Inactivated Polio Vaccine Upstream Market 10.3 Inactivated Polio Vaccine Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Inactivated Polio Vaccine Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer
List of Tables Table 1. Key Players of Inactivated Polio Vaccine in Global Market Table 2. Top Inactivated Polio Vaccine Players in Global Market, Ranking by Revenue (2021) Table 3. Global Inactivated Polio Vaccine Revenue by Companies, (US$, Mn), 2017-2022 Table 4. Global Inactivated Polio Vaccine Revenue Share by Companies, 2017-2022 Table 5. Global Inactivated Polio Vaccine Sales by Companies, (K Units), 2017-2022 Table 6. Global Inactivated Polio Vaccine Sales Share by Companies, 2017-2022 Table 7. Key Manufacturers Inactivated Polio Vaccine Price (2017-2022) & (US$/Unit) Table 8. Global Manufacturers Inactivated Polio Vaccine Product Type Table 9. List of Global Tier 1 Inactivated Polio Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share Table 10. List of Global Tier 2 and Tier 3 Inactivated Polio Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share Table 11. By Type – Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2021 & 2028 Table 12. By Type - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2017-2022 Table 13. By Type - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2023-2028 Table 14. By Type - Global Inactivated Polio Vaccine Sales (K Units), 2017-2022 Table 15. By Type - Global Inactivated Polio Vaccine Sales (K Units), 2023-2028 Table 16. By Application – Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2021 & 2028 Table 17. By Application - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2017-2022 Table 18. By Application - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2023-2028 Table 19. By Application - Global Inactivated Polio Vaccine Sales (K Units), 2017-2022 Table 20. By Application - Global Inactivated Polio Vaccine Sales (K Units), 2023-2028 Table 21. By Region – Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2021 VS 2028 Table 22. By Region - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2017-2022 Table 23. By Region - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2023-2028 Table 24. By Region - Global Inactivated Polio Vaccine Sales (K Units), 2017-2022 Table 25. By Region - Global Inactivated Polio Vaccine Sales (K Units), 2023-2028 Table 26. By Country - North America Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2022 Table 27. By Country - North America Inactivated Polio Vaccine Revenue, (US$, Mn), 2023-2028 Table 28. By Country - North America Inactivated Polio Vaccine Sales, (K Units), 2017-2022 Table 29. By Country - North America Inactivated Polio Vaccine Sales, (K Units), 2023-2028 Table 30. By Country - Europe Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2022 Table 31. By Country - Europe Inactivated Polio Vaccine Revenue, (US$, Mn), 2023-2028 Table 32. By Country - Europe Inactivated Polio Vaccine Sales, (K Units), 2017-2022 Table 33. By Country - Europe Inactivated Polio Vaccine Sales, (K Units), 2023-2028 Table 34. By Region - Asia Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2022 Table 35. By Region - Asia Inactivated Polio Vaccine Revenue, (US$, Mn), 2023-2028 Table 36. By Region - Asia Inactivated Polio Vaccine Sales, (K Units), 2017-2022 Table 37. By Region - Asia Inactivated Polio Vaccine Sales, (K Units), 2023-2028 Table 38. By Country - South America Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2022 Table 39. By Country - South America Inactivated Polio Vaccine Revenue, (US$, Mn), 2023-2028 Table 40. By Country - South America Inactivated Polio Vaccine Sales, (K Units), 2017-2022 Table 41. By Country - South America Inactivated Polio Vaccine Sales, (K Units), 2023-2028 Table 42. By Country - Middle East & Africa Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2022 Table 43. By Country - Middle East & Africa Inactivated Polio Vaccine Revenue, (US$, Mn), 2023-2028 Table 44. By Country - Middle East & Africa Inactivated Polio Vaccine Sales, (K Units), 2017-2022 Table 45. By Country - Middle East & Africa Inactivated Polio Vaccine Sales, (K Units), 2023-2028 Table 46. Sanofi Corporate Summary Table 47. Sanofi Inactivated Polio Vaccine Product Offerings Table 48. Sanofi Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 49. GSK Corporate Summary Table 50. GSK Inactivated Polio Vaccine Product Offerings Table 51. GSK Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 52. Bibcol Corporate Summary Table 53. Bibcol Inactivated Polio Vaccine Product Offerings Table 54. Bibcol Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 55. Serum Institute Corporate Summary Table 56. Serum Institute Inactivated Polio Vaccine Product Offerings Table 57. Serum Institute Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 58. Tiantan Biological Corporate Summary Table 59. Tiantan Biological Inactivated Polio Vaccine Product Offerings Table 60. Tiantan Biological Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 61. Panacea Biotec Corporate Summary Table 62. Panacea Biotec Inactivated Polio Vaccine Product Offerings Table 63. Panacea Biotec Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 64. Bio-Med Corporate Summary Table 65. Bio-Med Inactivated Polio Vaccine Product Offerings Table 66. Bio-Med Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 67. Halfkin Bio-Pharmaceuticals Corporate Summary Table 68. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Offerings Table 69. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022) Table 70. Inactivated Polio Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units) Table 71. Global Inactivated Polio Vaccine Capacity Market Share of Key Manufacturers, 2020-2022 Table 72. Global Inactivated Polio Vaccine Production by Region, 2017-2022 (K Units) Table 73. Global Inactivated Polio Vaccine Production by Region, 2023-2028 (K Units) Table 74. Inactivated Polio Vaccine Market Opportunities & Trends in Global Market Table 75. Inactivated Polio Vaccine Market Drivers in Global Market Table 76. Inactivated Polio Vaccine Market Restraints in Global Market Table 77. Inactivated Polio Vaccine Raw Materials Table 78. Inactivated Polio Vaccine Raw Materials Suppliers in Global Market Table 79. Typical Inactivated Polio Vaccine Downstream Table 80. Inactivated Polio Vaccine Downstream Clients in Global Market Table 81. Inactivated Polio Vaccine Distributors and Sales Agents in Global Market List of Figures Figure 1. Inactivated Polio Vaccine Segment by Type Figure 2. Inactivated Polio Vaccine Segment by Application Figure 3. Global Inactivated Polio Vaccine Market Overview: 2021 Figure 4. Key Caveats Figure 5. Global Inactivated Polio Vaccine Market Size: 2021 VS 2028 (US$, Mn) Figure 6. Global Inactivated Polio Vaccine Revenue, 2017-2028 (US$, Mn) Figure 7. Inactivated Polio Vaccine Sales in Global Market: 2017-2028 (K Units) Figure 8. The Top 3 and 5 Players Market Share by Inactivated Polio Vaccine Revenue in 2021 Figure 9. By Type - Global Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 10. By Type - Global Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 11. By Type - Global Inactivated Polio Vaccine Price (US$/Unit), 2017-2028 Figure 12. By Application - Global Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 13. By Application - Global Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 14. By Application - Global Inactivated Polio Vaccine Price (US$/Unit), 2017-2028 Figure 15. By Region - Global Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 16. By Region - Global Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 17. By Country - North America Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 18. By Country - North America Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 19. US Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 20. Canada Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 21. Mexico Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 22. By Country - Europe Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 23. By Country - Europe Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 24. Germany Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 25. France Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 26. U.K. Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 27. Italy Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 28. Russia Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 29. Nordic Countries Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 30. Benelux Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 31. By Region - Asia Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 32. By Region - Asia Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 33. China Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 34. Japan Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 35. South Korea Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 36. Southeast Asia Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 37. India Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 38. By Country - South America Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 39. By Country - South America Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 40. Brazil Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 41. Argentina Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 42. By Country - Middle East & Africa Inactivated Polio Vaccine Revenue Market Share, 2017-2028 Figure 43. By Country - Middle East & Africa Inactivated Polio Vaccine Sales Market Share, 2017-2028 Figure 44. Turkey Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 45. Israel Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 46. Saudi Arabia Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 47. UAE Inactivated Polio Vaccine Revenue, (US$, Mn), 2017-2028 Figure 48. Global Inactivated Polio Vaccine Production Capacity (K Units), 2017-2028 Figure 49. The Percentage of Production Inactivated Polio Vaccine by Region, 2021 VS 2028 Figure 50. Inactivated Polio Vaccine Industry Value Chain Figure 51. Marketing Channels
73
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined ... Read More
Synthetic peptide vaccines are usually composed of 20–30 amino acids containing the specific e ... Read More
Micro-needles are new form of dose delivery systems, which can easily overcome various problems a ... Read More
Dermabrasion is a surgical skin resurfacing procedure performed by the dermatologist or a plastic ... Read More